Cagrilintide and Semaglutide are both Metabolic peptides, but they're studied for different things. In short, Cagrilintide is a long-acting amylin analog studied for appetite and weight, often with semaglutide, while Semaglutide is a GLP-1 receptor agonist approved for type 2 diabetes and weight management. This page compares the two side by side — what each is researched for, how mature the evidence is, and how they're typically used — so you can see where they overlap and where they differ. It's educational information only, not medical advice, and neither is a substitute for a conversation with a licensed professional.
Cagrilintide vs Semaglutide at a glance
| Cagrilintide | Semaglutide | |
|---|---|---|
| Category | Metabolic | Metabolic |
| In short | A long-acting amylin analog studied for appetite and weight, often with semaglutide. | A GLP-1 receptor agonist approved for type 2 diabetes and weight management. |
| Researched for | Appetite regulation, Weight management, Satiety | Blood sugar regulation, Appetite & weight management, Cardiometabolic health |
| Research status | Clinical trials — investigational. | FDA-approved with large-scale human clinical trials. |
| Typically stacked with | Semaglutide | — |
| Key consideration | Investigational and not approved as a standalone product. Medical supervision advised. | Prescription medication with known side effects. Use only under medical supervision. |
How does Cagrilintide work?
Cagrilintide is a long-acting analog of amylin, a hormone co-released with insulin that promotes satiety and slows gastric emptying. It is studied on its own and combined with semaglutide (as CagriSema) for appetite and weight management.
How does Semaglutide work?
Semaglutide is a GLP-1 receptor agonist that mimics an incretin hormone released after eating. It slows gastric emptying, increases satiety, and improves insulin response — mechanisms that underpin its FDA-approved use in type 2 diabetes and chronic weight management.
Cagrilintide vs Semaglutide: how to choose
Choosing between Cagrilintide and Semaglutide really comes down to your specific goal — and it's a decision for you and a licensed professional, not something to settle from a web page. Cagrilintide is most associated with Appetite regulation and Weight management, while Semaglutide leans toward Blood sugar regulation and Appetite & weight management. Where they overlap, the practical differences are usually in mechanism and how far the research has actually progressed. The two are also commonly discussed together as a stack rather than as either/or. Selpho provides no dosing or protocols; if you'd like a research-backed steer for your goals, the free Peptide Advisor is a good starting point.
Frequently asked questions
Both are Metabolic peptides. Cagrilintide is a long-acting amylin analog studied for appetite and weight, often with semaglutide; Semaglutide is a GLP-1 receptor agonist approved for type 2 diabetes and weight management. They're most researched for Appetite regulation, Weight management (Cagrilintide) and Blood sugar regulation, Appetite & weight management (Semaglutide), respectively.
There's no universal "better" — it depends on your goal, and for most of these compounds robust head-to-head human evidence doesn't exist. The right choice is one made with a licensed professional. Selpho does not rank or prescribe; it offers educational information and a research-backed advisor.
Cagrilintide and Semaglutide are commonly discussed together as a stack in the research and community, based on complementary mechanisms. Selpho provides no dosing or protocols — any combination should only be considered with a licensed professional.
Cagrilintide: Clinical trials — investigational. Semaglutide: FDA-approved with large-scale human clinical trials.
Not sure which fits your goals?
Describe your situation and Selpho's free AI advisor will suggest research-backed peptides — no signup needed.
Try the Peptide AdvisorThis comparison is for educational purposes only and is not medical advice, a diagnosis, or a recommendation to use any compound. It contains no dosing or purchase information. Always consult a licensed healthcare professional before considering any peptide.